… occur in COVID-19, which is … in COVID-19. This state-of-the-art review will explore the
pathobiological mechanisms of immunothrombosis and VTE in COVID-19 focusing on: COVID-19-…

… coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism … prevalence of VTE in patients with COVID-19 who were totally …

… The systemic activation of blood coagulation and pulmonary thrombo-inflammation with local
vascular damage caused by COVID-19 may increase the risk of venous thromboembolism (…

… Hospitalized COVID-19 patients are often elderly, immobile, … intensive care unit for COVID-19
even under anticoagulant … of VTE on patients with COVID-19 will potentially improve our …

… We conducted a systematic literature search (MEDLINE, EMBASE, World Health Organization
COVID‐19 database) to identify studies reporting VTE rates in patients with COVID‐19. …

… The coronavirus disease 2019 (COVID-19) is reported to be associated with a high risk of
venous thromboembolism (VTE), which occurs in approximately 20% of COVID-19 patients …

Background The prevalence of venous thromboembolic event (VTE) and arterial
thromboembolic event (ATE) thromboembolic events in patients with COVID-19 remains largely …

… died of COVID-19, we found a high incidence of deep venous … thromboembolic events
in patients with COVID-19. When hemodynamic deterioration occurs in a patient with COVID-19…

Background: Coagulopathy associated with COVID-19 infection and venous thromboembolism
(VTE) have emerged as significant contributors to morbidity among patients infected with …

… Symptoms of PE overlap with symptoms of COVID-19 and mild symptoms may be … In early
April 2020, a large number of venous thromboembolic events were diagnosed in COVID-19 …